Pantoprazole Actavis

Pantoprazole, the active ingredient in Pantoprazole Actavis, is a proton pump inhibitor presented as an oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazole Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that reduces gastric acid production in several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): relieves heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: maintains a higher gastric pH to allow damaged esophageal tissue to heal. - Zollinger‑Ellison syndrome: controls excessive acid secretion caused by gastrin‑secreting tumors.

Pantoprazole may cause a range of adverse reactions. Most are mild and resolve after continued therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome). - Clostridioides difficile infection: severe colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Elevated liver enzymes or hepatitis. - Pancreatitis: inflammation of the pancreas. - Increased risk of bone fractures with long‑term therapy.

Before prescribing Pantoprazole, clinicians should consider several safety aspects.

- Assess renal and hepatic function: dose adjustment may be needed. - Use caution in elderly patients: higher risk of adverse effects. - Monitor serum magnesium during long‑term therapy. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Review all concomitant medications for potential interactions. - Store at room temperature: keep in the original pack, protect from moisture.

Pantoprazole can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activation. - Atazanavir: decreased absorption and efficacy. - HIV protease inhibitors (e.g., ritonavir): lowered plasma concentrations.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Phenytoin: reduced clearance, possible toxicity. - Fluconazole: elevated pantoprazole concentrations.